share_log

Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Market Cap Increased by CN¥634m, Insiders Receive a 46% Cut

Shenzhen Lifotronic Technology Co., Ltd.'s (SHSE:688389) Market Cap Increased by CN¥634m, Insiders Receive a 46% Cut

深圳利福电子科技有限公司's (SHSE: 688389) 市值增加了6.34亿元人民币,内部人士获得 46% 的下调
Simply Wall St ·  04/25 21:39

Key Insights

关键见解

  • Insiders appear to have a vested interest in Shenzhen Lifotronic Technology's growth, as seen by their sizeable ownership
  • 53% of the business is held by the top 6 shareholders
  • 23% of Shenzhen Lifotronic Technology is held by Institutions
  • 业内人士似乎对深圳利福强科技的增长有既得利益,从他们庞大的所有权可以看出
  • 53% 的业务由前6名股东持有
  • 深圳利福电子科技23%的股份由机构持有

To get a sense of who is truly in control of Shenzhen Lifotronic Technology Co., Ltd. (SHSE:688389), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company, around 46% to be precise, is individual insiders. Put another way, the group faces the maximum upside potential (or downside risk).

要了解谁真正控制了深圳利福电子科技有限公司(SHSE: 688389),了解业务的所有权结构非常重要。持有公司股份最多的集团是个人内部人士,准确地说约为46%。换句话说,该集团面临最大的上行潜力(或下行风险)。

As a result, insiders were the biggest beneficiaries of last week's 8.5% gain.

因此,内部人士是上周8.5%涨幅的最大受益者。

Let's delve deeper into each type of owner of Shenzhen Lifotronic Technology, beginning with the chart below.

让我们从下图开始,深入研究深圳Lifotronic Technology的每种类型的所有者。

ownership-breakdown
SHSE:688389 Ownership Breakdown April 26th 2024
SHSE: 688389 所有权明细 2024 年 4 月 26 日

What Does The Institutional Ownership Tell Us About Shenzhen Lifotronic Technology?

关于深圳利福强科技,机构所有权告诉我们什么?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

机构在向自己的投资者报告时通常会根据基准来衡量自己,因此,一旦股票被纳入主要指数,他们通常会对股票更加热情。我们预计大多数公司都会有一些机构在册,尤其是在它们正在成长的情况下。

Shenzhen Lifotronic Technology already has institutions on the share registry. Indeed, they own a respectable stake in the company. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shenzhen Lifotronic Technology, (below). Of course, keep in mind that there are other factors to consider, too.

深圳利福强科技已经在股份登记处设立了机构。事实上,他们拥有该公司可观的股份。这可能表明该公司在投资界具有一定程度的信誉。但是,最好谨慎行事,不要依赖机构投资者所谓的验证。他们也是,有时候会弄错。如果两个大型机构投资者试图同时抛售股票,股价大幅下跌的情况并不少见。因此,值得查看深圳立丰科技过去的盈利轨迹(见下文)。当然,请记住,还有其他因素需要考虑。

earnings-and-revenue-growth
SHSE:688389 Earnings and Revenue Growth April 26th 2024
SHSE: 688389 收益和收入增长 2024 年 4 月 26 日

Shenzhen Lifotronic Technology is not owned by hedge funds. Xiancheng Liu is currently the largest shareholder, with 29% of shares outstanding. Shenzhen Hanyu Biotechnology Partnership Enterprise (Limited Partnership) is the second largest shareholder owning 5.0% of common stock, and Ming Long Hu holds about 4.9% of the company stock. Ming Long Hu, who is the third-largest shareholder, also happens to hold the title of Member of the Board of Directors.

深圳利福强科技不归对冲基金所有。刘先成目前是最大股东,已发行股份的29%。深圳汉宇生物科技合伙企业(有限合伙)是第二大股东,拥有5.0%的普通股,胡明龙持有公司约4.9%的股份。第三大股东胡明龙也恰好拥有董事会成员的头衔。

On further inspection, we found that more than half the company's shares are owned by the top 6 shareholders, suggesting that the interests of the larger shareholders are balanced out to an extent by the smaller ones.

经过进一步检查,我们发现公司一半以上的股份由前六名股东持有,这表明较大股东的利益在一定程度上被较小的股东所平衡。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There are a reasonable number of analysts covering the stock, so it might be useful to find out their aggregate view on the future.

虽然研究公司的机构所有权可以为您的研究增加价值,但研究分析师的建议以更深入地了解股票的预期表现也是一种好做法。有相当数量的分析师在报道该股,因此了解他们对未来的总体看法可能很有用。

Insider Ownership Of Shenzhen Lifotronic Technology

深圳利福电子科技的内部所有权

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Company management run the business, but the CEO will answer to the board, even if he or she is a member of it.

尽管内部人士的确切定义可能是主观的,但几乎每个人都认为董事会成员是内部人士。公司管理层经营业务,但首席执行官将对董事会负责,即使他或她是董事会成员。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常认为内部所有权是一件好事。但是,在某些情况下,这使其他股东更难追究董事会对决策的责任。

Our information suggests that insiders maintain a significant holding in Shenzhen Lifotronic Technology Co., Ltd.. It is very interesting to see that insiders have a meaningful CN¥3.7b stake in this CN¥8.1b business. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

我们的信息表明,内部人士持有深圳Lifotronic科技有限公司的大量股份。有趣的是,内部人士在这项81亿元的业务中拥有37亿元人民币的大量股份。很高兴看到这样的投资水平。你可以在这里查看这些内部人士最近是否在买入。

General Public Ownership

一般公有制

The general public-- including retail investors -- own 20% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

包括散户投资者在内的公众拥有该公司20%的股份,因此不容忽视。尽管这种所有权规模可能不足以影响对他们有利的政策决定,但它们仍然可以对公司政策产生集体影响。

Private Company Ownership

私人公司所有权

Our data indicates that Private Companies hold 9.3%, of the company's shares. It's hard to draw any conclusions from this fact alone, so its worth looking into who owns those private companies. Sometimes insiders or other related parties have an interest in shares in a public company through a separate private company.

我们的数据显示,私营公司持有公司9.3%的股份。仅凭这一事实很难得出任何结论,因此值得研究谁拥有这些私营公司。有时,内部人士或其他关联方通过一家独立的私人公司对上市公司的股份拥有权益。

Next Steps:

后续步骤:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Case in point: We've spotted 1 warning sign for Shenzhen Lifotronic Technology you should be aware of.

我觉得看看究竟谁拥有一家公司非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。一个很好的例子:我们发现了你应该注意的深圳利福电子科技的1个警告信号。

If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

如果你像我一样,你可能需要考虑这家公司是会成长还是会萎缩。幸运的是,您可以查看这份免费报告,其中显示了分析师对其未来的预测。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的数字是使用过去十二个月的数据计算得出的,这些数据是指截至财务报表日期当月最后一天的12个月期间。这可能与全年年度报告数据不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发